U.S. Transportation Stock News

NasdaqGS:BYND
NasdaqGS:BYNDFood

Why Beyond Meat (BYND) Is Down 9.3% After Q1 Results And Functional Beverage Pivot News

Beyond Meat has recently reported first-quarter 2026 results, with net revenues of US$58.21 million versus US$68.73 million a year earlier, and a reduced net loss of US$28.48 million, while also completing follow-on equity offerings and filing a US$10.40 million shelf registration tied to employee stock plans. Alongside cost cuts and lower cash use, the company is pivoting beyond plant-based meat into functional food and beverages, including its new Beyond Immerse protein drink distributed...
NasdaqCM:PSIX
NasdaqCM:PSIXElectrical

How Investors May Respond To Power Solutions International (PSIX) Data Center Capacity Misstatement Lawsuits

In recent months, multiple law firms have launched securities class action lawsuits against Power Solutions International, alleging false and misleading statements about its ability to meet data center sales demand and manage related manufacturing costs between May 2025 and March 2026. The wave of similar complaints highlights how disclosures about operational inefficiencies and gross margin pressure can rapidly shift legal, operational, and governance risks for shareholders. Next, we’ll...
NYSE:RAMP
NYSE:RAMPSoftware

A Look At LiveRamp (RAMP) Valuation After Launch Of GPU Optimized AI Clean Rooms

LiveRamp Holdings (RAMP) recently introduced GPU-optimized clean rooms with native support for NVIDIA AI infrastructure, allowing AI partners and brands to train and deploy complex marketing models at significantly higher speeds while keeping underlying data and model weights protected. See our latest analysis for LiveRamp Holdings. The GPU clean room announcement comes on top of a strong run in the stock, with a 90 day share price return of 29.99% and a 1 year total shareholder return of...
NYSE:CVSA
NYSE:CVSAConsumer Services

Will Covista’s (CVSA) AI Healthcare Pivot With Google Cloud and Earnings Beat Change Its Narrative?

Covista Inc. has already reported third-quarter fiscal 2026 results, with sales rising to US$487.03 million while net income eased to US$41.64 million, and announced an AI-powered healthcare education partnership with Google Cloud that is drawing strong interest in its new professional certificate programs. Together, the earnings beat, higher full-year guidance and rapid uptake of the AI-enabled courses suggest Covista is increasingly leaning on higher-margin digital offerings to support its...
NYSE:LNN
NYSE:LNNMachinery

Did Legal Probe and Weaker Quarter Just Shift Lindsay's (LNN) Governance and Transparency Narrative?

Pomerantz LLP has begun investigating Lindsay Corporation for potential securities law violations after the company reported year-over-year declines in revenue and earnings for the quarter ended February 28, 2026. This combination of legal scrutiny and weaker quarterly performance raises fresh questions about how Lindsay’s governance and disclosure practices align with investor expectations. Next, we will examine how the new securities investigation, alongside weaker quarterly results, may...
NasdaqGM:SUPN
NasdaqGM:SUPNPharmaceuticals

Supernus Pharmaceuticals (SUPN) Is Up 8.9% After Q1 Beat And Reaffirmed 2026 Outlook Has The Bull Case Changed?

In early May 2026, Supernus Pharmaceuticals, Inc. reported first-quarter 2026 results showing revenue of US$207.71 million versus US$149.82 million a year earlier, with net loss narrowing to US$2.29 million from US$11.83 million. On the same day, the company reiterated its full-year 2026 outlook, projecting total revenues of US$840 million–US$870 million and operating earnings of US$0–US$30 million, signalling management’s confidence in its current trajectory. We’ll now examine how...
NasdaqGS:ADPT
NasdaqGS:ADPTLife Sciences

A Look At Adaptive Biotechnologies (ADPT) Valuation After Strong Q1 MRD Growth And Raised Full Year Guidance

First quarter MRD momentum and guidance raise Adaptive Biotechnologies (ADPT) is back in focus after first quarter 2026 results highlighted strong Minimal Residual Disease, or MRD, revenue trends and a higher full year MRD revenue outlook of US$260 million to US$270 million. See our latest analysis for Adaptive Biotechnologies. The first quarter update has come alongside a 1-month share price return of 7.15% and a year to date share price decline of 7.67%. The 1-year total shareholder return...
NasdaqGM:WINA
NasdaqGM:WINASpecialty Retail

Winmark (WINA) Valuation Check After Board Refresh And New Director Equity Incentives

Winmark (WINA) is in focus after the company outlined upcoming board changes, with long-serving director Lawrence A. Barbetta set to step down and marketing executive Stephanie S. Hoppe joining the board. See our latest analysis for Winmark. The board changes arrive after a softer run for the stock, with a 30-day share price return of a 13.0% decline and a 90-day share price return of an 18.7% decline. The 5-year total shareholder return of 120.1% points to much stronger longer term...
NYSE:CIM
NYSE:CIMMortgage REITs

Assessing Chimera Investment (CIM) Valuation After HomeXpress Acquisition And Mixed Performance Signals

Key snapshot for Chimera Investment Chimera Investment (CIM) has drawn attention after recent share performance data, with the stock last closing at US$13.54 and showing mixed returns over the past week, month and past 3 months. See our latest analysis for Chimera Investment. Recent trading has been choppy, with a 1-day share price return of -0.66% and a 7-day share price return of -1.53%. At the same time, the 1-year total shareholder return of 19.27% and 3-year total shareholder return of...
NasdaqGS:LBTY.A
NasdaqGS:LBTY.ATelecom

Why Liberty Global (LBTY.A) Is Up 6.0% After Swinging Back To Q1 Profitability – And What's Next

Liberty Global Ltd. has reported its first-quarter 2026 results, with sales rising to US$1,274.6 million and net income reaching US$337.8 million, compared with a net loss a year earlier. This move from a very large loss to positive earnings per share from continuing operations suggests a meaningful shift in the company’s recent operating performance. Next, we will examine how this return to quarterly profitability could affect Liberty Global’s investment narrative built around fiber and...
NYSE:CPK
NYSE:CPKGas Utilities

How Chesapeake Utilities’ Strong Q1 Results and Dividend Hike Could Shape CPK Investors’ Outlook

In early May 2026, Chesapeake Utilities Corporation reported first-quarter 2026 results showing higher sales of US$363 million, revenue of US$353.1 million, and net income of US$59.3 million, alongside an increase in diluted earnings per share from continuing operations to US$2.47 compared with a year earlier. At the same time, the company’s board approved a 7.3% increase in the quarterly dividend to US$0.735 per share, reinforcing its long-standing pattern of uninterrupted and annually...
NasdaqGS:OSIS
NasdaqGS:OSISElectronic

Are OSI Systems' (OSIS) Margin Pressures Undermining Its Steady Revenue Guidance?

In early May 2026, OSI Systems, Inc. reported third-quarter revenue of US$453.25 million and nine‑month revenue of US$1.30 billion, alongside slightly lower quarterly earnings, while reiterating its fiscal 2026 revenue guidance range of US$1.83 billion to US$1.87 billion. The combination of revenue growth, compressed margins, unchanged full‑year earnings guidance, and insider share sales has drawn attention to the company’s profitability trajectory and cost discipline. With profitability...
NasdaqGS:OSBC
NasdaqGS:OSBCBanks

Old Second Bancorp (OSBC) Valuation Check After Q1 2026 Earnings And Higher Credit Costs

Q1 2026 earnings event reshapes the story Old Second Bancorp (OSBC) just posted Q1 2026 results that combine higher net income, a completed acquisition that expanded assets and footprint, and a clear rise in credit costs tied to problem loans. See our latest analysis for Old Second Bancorp. At a share price of $21.08, Old Second Bancorp has a year to date share price return of 8.21%. Its 1 year total shareholder return of 27.57% and 3 year total shareholder return of 95.98% point to momentum...
NasdaqCM:PGY
NasdaqCM:PGYSoftware

Three Founder Led Stocks With Premium Brands And Hidden Firepower

With inflation readings still elevated in many countries, bond yields reacting to every policy hint and trade flows shifting across regions, it is easy to feel stuck on the sidelines. One way to cut through the noise is to focus on founder-led companies where leadership has real skin in the game and capital is used carefully. This screener does exactly that, filtering for businesses where founders are still in charge and closely aligned with shareholders. In this article, you will see three...
NYSE:ATMU
NYSE:ATMUMachinery

Atmus Filtration Technologies (ATMU) Valuation After Strong Q1 2026 Results And Reaffirmed Earnings Guidance

Atmus Filtration Technologies (ATMU) is back in focus after reporting first quarter 2026 results, with higher sales and net income than a year ago, and reaffirmed full year 2026 earnings guidance. See our latest analysis for Atmus Filtration Technologies. The reaffirmed 2026 guidance and recent buyback activity come against a mixed trading backdrop, with a 1 day share price return of 1.09%, a 7 day share price decline of 13.50%, a year to date share price return of 4.64%, and a 1 year total...
NYSE:DFIN
NYSE:DFINCapital Markets

Is Donnelley Financial (DFIN) Balancing Softer Guidance With a Stronger Software Story?

Donnelley Financial Solutions recently reported first-quarter 2026 results showing revenue of US$205.5 million and net income of US$33.5 million, with earnings per share rising year on year. The company also issued second-quarter sales guidance and highlighted growing demand for its software platforms as clients adapt to evolving SEC reporting rules. Now we will examine how this earnings update and softer revenue guidance may influence Donnelley Financial Solutions’ existing investment...
NasdaqGS:ALKS
NasdaqGS:ALKSBiotechs

Evaluating Alkermes (ALKS) Valuation After Recent Share Price Momentum

Context for Alkermes stock Alkermes (ALKS) has been on investors’ radar after recent share price moves, with the stock showing gains over the past week, month, and past 3 months that stand out against its longer term return profile. With the company valued at about US$5.9b and reporting revenue of US$1.6b and net income of US$152.7m, many investors are now focusing on whether the current valuation still reflects its fundamentals. See our latest analysis for Alkermes. At the current share...
NasdaqGM:VITL
NasdaqGM:VITLFood

A Look At Vital Farms (VITL) Valuation After Q1 2026 Loss, Outlook Cut And Butter Exit

Vital Farms (VITL) has drawn fresh investor attention after Q1 2026 results showed sales of US$187.16 million, alongside a net loss, a lower full year outlook, and a planned exit from its butter business. See our latest analysis for Vital Farms. The share price reaction has been severe, with a 1 day share price return of 20.7% and a year to date share price return of 68.1%. At the same time, the 1 year total shareholder return of 70.8% and 5 year total shareholder return of 52.2% point to...
NYSE:UTZ
NYSE:UTZFood

Evaluating Utz Brands (UTZ) Valuation After Recent Share Price Weakness

What recent performance suggests about Utz Brands (UTZ) Utz Brands (UTZ) has been on investors’ radars after a mixed run, with the stock roughly flat over the past month but showing a return decline over the past 3 months and past year. At a last close of US$7.72 and a market cap of about US$1.19b, the company sits in an interesting spot for snack sector investors who are weighing current pricing against its recent performance profile. See our latest analysis for Utz Brands. For context, Utz...
NasdaqGS:EYE
NasdaqGS:EYESpecialty Retail

Did Wall Street’s Q1 2026 Expectations Just Reframe National Vision Holdings’ (EYE) Investment Narrative?

National Vision Holdings is set to report its Q1 2026 results on May 13, with Wall Street expecting earnings per share of US$0.43 and revenue growth alongside higher comparable store sales. Analysts are watching for signs of improved operating leverage and margin performance, as well as how management characterizes consumer demand and competition across its optical retail formats. With expectations for higher earnings and mid-single-digit revenue growth, we'll examine how this upcoming...
NasdaqGS:SGRY
NasdaqGS:SGRYHealthcare

A Look At Surgery Partners (SGRY) Valuation After Reaffirmed Guidance And Positive First Quarter Results

Key earnings takeaways for Surgery Partners (SGRY) Surgery Partners (SGRY) kicked off 2026 with first quarter results that paired revenue growth with a narrower loss, while management reaffirmed full year guidance and highlighted ongoing cost discipline and portfolio work. The company reported Q1 revenue of US$810.9 million, basic and diluted loss per share from continuing operations of US$0.28, and an overall net loss of US$35.9 million. Management reiterated full year 2026 revenue guidance...